In The News Posted May 27, 2020 Share Posted May 27, 2020 GENEVA, May 27, 2020 /PRNewswire/ -- iOnctura SA, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, today announces that it has appointed Dr. Joanna Horobin as non-executive Chair to the iOnctura Board with...View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.